Clinical Trials Directory

Trials / Unknown

UnknownNCT05151055

Lactoferrin + Vitamin E + Zinc for Hormonal Acne

A Randomized, Double-Blind, Placebo-Controlled Trial To Determine The Safety and Efficacy of Lactoferrin With Vitamin E and Zinc as an Oral Therapy for Mild to Moderate Hormonal Acne in Adult Women

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
136 (estimated)
Sponsor
United Laboratories · Industry
Sex
Female
Age
22 Years – 50 Years
Healthy volunteers
Accepted

Summary

We previously showed that twice daily intake of a combination of 100 mg lactoferrin, 11 IU vitamin E, and 5 mg zinc significantly reduced both inflammatory and non-inflammatory acne lesions compared to placebo control. In that study, females showed an overall better response compared to males in terms of total lesions. We speculated that the gender effect may be due to mitigation of the pre- menstrual flare-ups women have that lead to recurring acne, making them have a better response. The objectives of this study are: 1.) to characterize the efficacy and safety of 100 mg lactoferrin + 11 IU vitamin E + 5 mg zinc in the adult female population who suffer from hormonal acne, 2.) to determine whether the anti-acne effect is maintained after treatment stops.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLactezin100 mg lactoferrin, 11 IU vitamin E (as alpha tocopherol), and 5 mg zinc (as zinc gluconate)
DIETARY_SUPPLEMENTPlacebostarch

Timeline

Start date
2020-03-02
Primary completion
2022-06-01
Completion
2022-09-01
First posted
2021-12-09
Last updated
2021-12-09

Locations

1 site across 1 country: Philippines

Source: ClinicalTrials.gov record NCT05151055. Inclusion in this directory is not an endorsement.